Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changye Zou

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Cell Death & Disease|July 17, 2023
Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcomaWeitang Guo, Xin Wang, Bing Lu, et al.
Cancer Medicine|May 22, 2023
Preoperative denosumab treatment in patients with giant cell bone tumors in limbs: A retrospective study using propensity score matchingYongfu Huang, Mingxian Xu, Bo Wang, et al.
Molecular Cancer Research : MCR|October 17, 2019
Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in OsteosarcomaBing Lu, Yangyang He, Jincan He, et al.
Cancer|October 20, 2011
Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosisChangye Zou, Jingnan Shen, Qinglian Tang, et al.
BMC Cancer|December 1, 2018
Comparison of clinical features, management and outcomes of osteosarcoma located in proximal fibula and proximal tibia: a propensity score matching analysisHao Yao, Bo Wang, Lili Wen, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|May 23, 2014
[Role of SCUBE3 in promoting osteosarcoma cell growth and its association with prognosis]Guohui Song, Jin Wang, Jinchang Lu, et al.
American Journal of Translational Research|July 14, 2020
CB-5083, an inhibitor of P97, suppresses osteosarcoma growth and stem cell properties by altering protein homeostasisZhiqiang Zhao, Mansi Wu, Xuelin Zhang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 15, 2025
A prediction model of pulmonary metastasis risk in pediatric patients with stage IIB osteosarcoma in the long bone of extremitiesGuodong Zhong, Wanzhen Wang, Aierxiding Aimaiti, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|June 28, 2013
[Expression of chemokine CXCL14 in primary osteosarcoma and its association with prognosis]Jinchang Lu, Jin Wang, Bicheng Yong, et al.
Orthopaedic Surgery|November 27, 2025
The Application of Orthopedic Surgical Robot-Assisted Technology in Various Clinical Scenarios Involving Bone TumorsHanxiao Yin, Yiwei Fu, Xirenijiang Yikemu, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Cell Death & Disease|July 17, 2023
Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcomaWeitang Guo, Xin Wang, Bing Lu, et al.
Cancer Medicine|May 22, 2023
Preoperative denosumab treatment in patients with giant cell bone tumors in limbs: A retrospective study using propensity score matchingYongfu Huang, Mingxian Xu, Bo Wang, et al.
Molecular Cancer Research : MCR|October 17, 2019
Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in OsteosarcomaBing Lu, Yangyang He, Jincan He, et al.
Cancer|October 20, 2011
Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosisChangye Zou, Jingnan Shen, Qinglian Tang, et al.
BMC Cancer|December 1, 2018
Comparison of clinical features, management and outcomes of osteosarcoma located in proximal fibula and proximal tibia: a propensity score matching analysisHao Yao, Bo Wang, Lili Wen, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|May 23, 2014
[Role of SCUBE3 in promoting osteosarcoma cell growth and its association with prognosis]Guohui Song, Jin Wang, Jinchang Lu, et al.
American Journal of Translational Research|July 14, 2020
CB-5083, an inhibitor of P97, suppresses osteosarcoma growth and stem cell properties by altering protein homeostasisZhiqiang Zhao, Mansi Wu, Xuelin Zhang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 15, 2025
A prediction model of pulmonary metastasis risk in pediatric patients with stage IIB osteosarcoma in the long bone of extremitiesGuodong Zhong, Wanzhen Wang, Aierxiding Aimaiti, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|June 28, 2013
[Expression of chemokine CXCL14 in primary osteosarcoma and its association with prognosis]Jinchang Lu, Jin Wang, Bicheng Yong, et al.
Orthopaedic Surgery|November 27, 2025
The Application of Orthopedic Surgical Robot-Assisted Technology in Various Clinical Scenarios Involving Bone TumorsHanxiao Yin, Yiwei Fu, Xirenijiang Yikemu, et al.
Pageof 7